These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 1804804)

  • 1. Antitumor activities of new platinum compounds, DWA2114R, NK121 and 254-S, against human leukemia cells sensitive or resistant to cisplatin.
    Kobayashi H; Takemura Y; Miyachi H; Ogawa T
    Invest New Drugs; 1991 Nov; 9(4):313-9. PubMed ID: 1804804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor effects of three platinum complexes, (-)-(R)-2-aminomethylpyrrolidine(1,1-cyclobutanedicarboxylato)-platinum (II) monohydrate (DWA2114R), cis-diammine-(1,1-cyclobutanedicarboxylato)platinum(II) (CBDCA) and cis-diamminedichloroplatinum(II) (CDDP), in mice.
    Endo K; Akamatsu K; Matsumoto T; Morikawa K; Koizumi M; Mitsui H; Koizumi K
    Anticancer Res; 1992; 12(1):49-58. PubMed ID: 1567181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flow cytometric analyses of the characteristics of tumor cells treated with two platinum compounds: 1,1-cyclobutanedicarboxylato(2-aminomethylpyrrolidine)- platinum(II) and cisplatin.
    Inoue S; Mizuno S; Ito M; Ohnuma T
    Jpn J Cancer Res; 1992 Nov; 83(11):1231-40. PubMed ID: 1483936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor activity and cellular accumulation of a new platinum complex, (-)-(R)-2-aminomethylpyrrolidine(1,1-cyclobutanedicarboxylato)platinum( II) monohydrate, in cisplatin-sensitive and -resistant murine P388 leukemia cells.
    Kamisango K; Matsumoto T; Akamatsu K; Morikawa K; Tashiro T; Koizumi K
    Jpn J Cancer Res; 1992 Mar; 83(3):304-11. PubMed ID: 1582895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heat enhances the cytotoxicity of cis-diamminedichloroplatinum(II) and its analogues cis-1,1-cyclobutane-dicarboxylato(2R)-2-methyl-1,4- butanediammineplatinum(II) and cis-diammine(glycolato)platinum in vitro.
    Takahashi I; Maehara Y; Kusumoto H; Kohnoe S; Sugimachi K
    Cancer Chemother Pharmacol; 1993; 33(1):31-5. PubMed ID: 8269586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro antitumor activity of a new platinum complex, DWA2114R against human tumor cell lines.
    Akamatsu K; Saito H; Tsunenari T; Matsumoto T; Morikawa K; Koizumi M; Mitsui H; Koizumi K
    Anticancer Res; 1993; 13(6A):2261-5. PubMed ID: 8297143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of cis-diamminedichloro-platinum(II) and its analogues cis-1,1- cyclobutanedicarboxylato(2R)-2-methyl-1,4-butanediammineplatinum(II) and cis-diammine(glycolato)platinum with hyperthermia in vivo.
    Takahashi I; Maehara Y; Kusumoto H; Kusumoto T; Baba H; Kohnoe S; Sugimachi K
    Oncology; 1996; 53(1):68-72. PubMed ID: 8570136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor activity of platinum analogs against human lung cancer cell lines and tumor specimens.
    Yonei T; Ohnoshi T; Hiraki S; Ueoka H; Kiura K; Moritaka T; Shibayama T; Tabata M; Segawa Y; Takigawa N
    Acta Med Okayama; 1993 Aug; 47(4):233-41. PubMed ID: 8213217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resistance and cross-resistance of the IgM immunocytoma in the LOU/M Wsl rat for cisplatin, carboplatin, and iproplatin.
    Steerenberg PA; Vendrik CP; de Jong WH; de Groot G; Fichtinger-Schepman AM; Scheefhals AP; Schornagel JH
    Cancer Chemother Pharmacol; 1988; 22(1):51-7. PubMed ID: 3293840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishment and characterization of acquired resistance to platinum anticancer drugs in human ovarian carcinoma cells.
    Misawa T; Kikkawa F; Maeda O; Obata NH; Higashide K; Suganuma N; Tomoda Y
    Jpn J Cancer Res; 1995 Jan; 86(1):88-94. PubMed ID: 7737915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo antineoplastic activity of a new platinum antineoplastic agent, (R)-(-)-1,1-cyclobutanedicarboxylate (2-aminomethylpyrrolidine)-platinum (II) (DWA2114R) on freshly separated human tumor cells and human tumor xenografts transplanted in nude mice--a comparison with cis-diammine-dichloroplatinum (CDDP).
    Nio Y; Imai S; Shiraishi T; Tsubono M; Morimoto H; Tseng CC; Tobe T
    Anticancer Res; 1991; 11(2):761-7. PubMed ID: 2064331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of carrier ligand in platinum resistance of human carcinoma cell lines.
    Schmidt W; Chaney SG
    Cancer Res; 1993 Feb; 53(4):799-805. PubMed ID: 8428361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cisplatinum compounds].
    Ota K
    Gan To Kagaku Ryoho; 1993 Jan; 20(1):50-8. PubMed ID: 8380687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro evaluation of platinum, titanium and ruthenium metal complexes in cisplatin-sensitive and -resistant rat ovarian tumors.
    Frühauf S; Zeller WJ
    Cancer Chemother Pharmacol; 1991; 27(4):301-7. PubMed ID: 1998986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antitumor activity of a new platinum complex (R)-(-)-2-aminomethylpyrrolidine (1,1-cyclobutane dicarboxylato) platinum (II) (DWA2114R) by its serial administration].
    Akamatsu K; Endo K; Matsumoto T; Kamisango K; Morikawa K; Koizumi M; Mitsui H; Koizumi K; Matsuno T
    Gan To Kagaku Ryoho; 1989 May; 16(5):2039-43. PubMed ID: 2658840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of trans-tetrachloro-1,2-diaminocyclohexane platinum (IV) in murine leukemia L1210 resistant and sensitive to cis-diamminedichloroplatinum (II).
    Wilkoff LJ; Dulmadge EA; Trader MW; Harrison SD; Griswold DP
    Cancer Chemother Pharmacol; 1987; 20(2):96-100. PubMed ID: 3664938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of treatment schedule of an antitumor platinum complex, DWA2114R, on the antitumor activity].
    Endo K; Akamatsu K; Matsumoto T; Morikawa K; Koizumi M; Mitsui H; Koizumi K
    Gan To Kagaku Ryoho; 1992 Feb; 19(2):223-8. PubMed ID: 1736834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of cytotoxicity and cellular pharmacology of 1,2-diaminocyclohexane platinum (IV) complexes mediated by axial and equatorial ligands.
    Kido Y; Khokhar AR; al-Baker S; Siddik ZH
    Cancer Res; 1993 Oct; 53(19):4567-72. PubMed ID: 8402629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor activity, induction of cross-resistance, and nephrotoxicity of a new platinum analogue, cis-1,1-diaminomethylcyclohexaneplatinum(II) sulfate, and of cis-diamminedichloroplatinum(II) in an immunocytoma model in the LOU/M rat.
    de Jong WH; Steerenberg PA; Vos JG; Bulten EJ; Verbeek F; Kruizinga W; Ruitenberg EJ
    Cancer Res; 1983 Oct; 43(10):4927-34. PubMed ID: 6683993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potent antitumour activity of (-)-(R)-2-aminomethylpyrrolidine (1,1-cyclobutanedicarboxylato)platinum(II) monohydrate (DWA2114R) against advanced L1210 leukaemia in mice.
    Akamatsu K; Endo K; Matsumoto T; Kamisango K; Morikawa K; Koizumi M; Koizumi K
    Br J Cancer; 1992 Nov; 66(5):827-32. PubMed ID: 1419625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.